First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
Saved in:
| Title: | First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial. |
|---|---|
| Authors: | Waalewijn H; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa., Szubert AJ; Medical Research Council Clinical Trials Unit, University College London, United Kingdom., Wasmann RE; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa., Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa., Chabala C; Department of Paediatrics and Child Health, School of Medicine, University of Zambia.; Children's Hospital, University Teaching Hospital, Lusaka, Zambia., Bwakura-Dangarembizi M; University of Zimbabwe Clinical Research Centre, Harare., Makumbi S; Joint Clinical Research Centre, Mbarara Regional Centre of Excellence, Mbarara, Uganda., Nangiya J; Joint Clinical Research Centre, Research Department, Kampala, Uganda., Mumbiro V; University of Zimbabwe Clinical Research Centre, Harare., Mulenga V; Children's Hospital, University Teaching Hospital, Lusaka, Zambia., Musiime V; Joint Clinical Research Centre, Research Department, Kampala, Uganda.; Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda., Monkiewicz LN; Medical Research Council Clinical Trials Unit, University College London, United Kingdom., Griffiths AL; Medical Research Council Clinical Trials Unit, University College London, United Kingdom., Bamford A; Medical Research Council Clinical Trials Unit, University College London, United Kingdom.; Infection, Immunity & Inflammation Department, UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Doerholt K; Medical Research Council Clinical Trials Unit, University College London, United Kingdom.; Paediatric Infectious Diseases Unit, St George's University Hospital, London, United Kingdom., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa., Burger DM; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Gibb DM; Medical Research Council Clinical Trials Unit, University College London, United Kingdom., McIlleron HM; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa., Colbers A; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. |
| Corporate Authors: | Children with HIV in Africa – Pharmacokinetics and Acceptability of Simple second-line antiretroviral regimens (CHAPAS-4) Trial Team |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 Sep 18; Vol. 77 (6), pp. 875-882. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciad267 |
